Not registered yet? Get a free account.

Sign Up
search icon cancel icon
Elomatic-Pharmalab Consulting And Engineering Location T. Score People Network Registered Details

ELOMATIC-PHARMALAB CONSULTING AND ENGINEERING PRIVATE LIMITED

www.elomatic.com
Active
Updated: 14 Oct 2024

Elomatic-Pharmalab Consulting And Engineering Private Limited, is an unlisted private company incorporated on 27 October, 2004. It is classified as a private limited company and is located in Thane, Maharashtra. It's authorized share capital is INR 7.50 cr and the total paid-up capital is INR 5.17 cr.

Elomatic-Pharmalab Consulting And Engineering's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2022. It's EBITDA has increased by 40.92% over the previous year. At the same time, it's book networth has increased by 33.9%.

Read more

Industry

Research and Development
Products
  • Process Engg, Basic & Detailed Engineering, Project Mgmt, GMP Audit, Concept, Validation at site, Engineering & Consulting Solutions, and Biotech, FAT & SAT, Facility Design, Virtual walk through 3D-Modelling, Purchase / Procurement Consultancy
Key Metrics

** All rupee values in INR crores. Based on March 2022 numbers.

Sales
57.6%
₹ GET PRO
EBITDA
40.92%
₹ GET PRO
Net Profit
40.44%
₹ GET PRO
Networth
33.9%
₹ GET PRO
Borrowings
-
₹ GET PRO
Assets
7.0%
₹ GET PRO
Gross Margin
-
GET PRO%
Operating Margin
-1.16
GET PRO%
Net Profit Margin
-0.96
GET PRO%
Return on Equity
1.18
GET PRO%
ROCE
-2.39
GET PRO%
Debt to Equity
-0.08
GET PRO
Sales
Mar 2022
Net worth
Mar 2022

Locations

indian flag India (2)
State Type Address

location icon Locations on Map

Map placeholder

Tofler Score

score img
Poor
Fair
Good
Very Good
Excellent

Risk

Severe Risk
  • No risks identified
Moderate Risk
  • No risks identified
Low Risk
  • No risks identified
About Tofler Score
Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Read more

Financial Highlights

** All numbers in INR crores
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Sales GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Gross margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin GET PRO GET PRO GET PRO GET PRO GET PRO
Networth
Borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Debt to equity GET PRO GET PRO GET PRO GET PRO GET PRO
Current ratio GET PRO GET PRO GET PRO GET PRO GET PRO
ROE GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
WC days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Margins

Gross margin
Operating margin
Net margin

Balance Sheet

%
** All numbers in INR crores
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity Capital GET PRO GET PRO GET PRO GET PRO GET PRO
Reserves GET PRO GET PRO GET PRO GET PRO GET PRO
Borrowings + GET PRO GET PRO GET PRO GET PRO GET PRO
Long term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Short term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Trade payables + GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
Other liabilities + GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Other current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Total liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Tangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
CWIP GET PRO GET PRO GET PRO GET PRO GET PRO
Intangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
LT loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Current assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Inventories GET PRO GET PRO GET PRO GET PRO GET PRO
Trade receivables GET PRO GET PRO GET PRO GET PRO GET PRO
Cash and cash equivalents GET PRO GET PRO GET PRO GET PRO GET PRO
ST loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total assets GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Total assets

Profit & Loss

%
** All numbers in INR crores
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Sales + GET PRO GET PRO GET PRO GET PRO GET PRO
Sales growth % GET PRO GET PRO GET PRO GET PRO GET PRO
Expenses + GET PRO GET PRO GET PRO GET PRO GET PRO
Cost of goods GET PRO GET PRO GET PRO GET PRO GET PRO
Employee cost GET PRO GET PRO GET PRO GET PRO GET PRO
Other costs GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit + GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin % GET PRO GET PRO GET PRO GET PRO GET PRO
Other income GET PRO GET PRO GET PRO GET PRO GET PRO
Interest GET PRO GET PRO GET PRO GET PRO GET PRO
Depreciation GET PRO GET PRO GET PRO GET PRO GET PRO
Exceptional items GET PRO GET PRO GET PRO GET PRO GET PRO
Profit before tax GET PRO GET PRO GET PRO GET PRO GET PRO
Tax GET PRO GET PRO GET PRO GET PRO GET PRO
Profit - disc. ops GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin % GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Revenue from operations

Ratios

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Solvency +
Total Debt/Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Net Debt/Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Total Debt/Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total Assets/Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Liquidity +
Current Ratio GET PRO GET PRO GET PRO GET PRO GET PRO
Quick Ratio GET PRO GET PRO GET PRO GET PRO GET PRO
Interest Coverage GET PRO GET PRO GET PRO GET PRO GET PRO
Performance
Gross Margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating Margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net Margin GET PRO GET PRO GET PRO GET PRO GET PRO
Return +
Return on Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Pre-tax ROCE GET PRO GET PRO GET PRO GET PRO GET PRO
Return on Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Pre-tax ROIC GET PRO GET PRO GET PRO GET PRO GET PRO
Efficiency +
Days Payable GET PRO GET PRO GET PRO GET PRO GET PRO
Days Inventory GET PRO GET PRO GET PRO GET PRO GET PRO
Days Receivable GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Asset Turnover GET PRO GET PRO GET PRO GET PRO GET PRO
Total Asset Turnover GET PRO GET PRO GET PRO GET PRO GET PRO
Working Capital
Cash Conversion Cycle GET PRO GET PRO GET PRO GET PRO GET PRO
Working Capital Days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Ratios

Current ratio
Debt/equity ratio

People

Designation Name DIN/PAN Tenure
Director Umesh Purushottam Shah 00257106 20 years
Director Tero Seppo Juhani Tuomela 07264465 9 years
Additional Director Vishal Umesh Shah 08657116 4 years
Director Mona Akerholm Daniela 09571186 3 years
Director Tom Henrik Lind 10698152 0 years

Company Network

Companies connected through Directors

Name Status Paid up Capital Common Directors Address
PHARMALAB INDIA PRIVATE LIMITED
Amalgamated
5.0 L 1 Maharashtra
LIQUIPACK SYSTEMS PRIVATE LIMITED
Active
3.9 Cr 1 Maharashtra
SERAIL PHARMALAB INDIA LIMITED
Strike Off
5.0 L 1 Maharashtra
PHARMALAB INDIA PRIVATE LIMITED.
Active
1.2 Cr 2 Maharashtra

Registered Details

CIN

U73100MH2004PTC149278

PAN

AABCE3791N

Incorporation

2004, 20.2 years

Company Email

prasad_panicker@pharmalab.com

Paid up Capital

₹ 5.2 Cr

Authorised Capital

₹ 7.5 Cr

AGM

Sep 2023

Type

Private
Non-government Company

Last Balance Sheet Date

Mar 2023 Updated on : 14 Oct 2024
* This is the date provided by MCA, but availability for this year is not guaranteed.

FAQ - ELOMATIC-PHARMALAB CONSULTING AND ENGINEERING PRIVATE LIMITED

What is the incorporation date of ELOMATIC-PHARMALAB CONSULTING AND ENGINEERING PRIVATE LIMITED?

plus icon

The incorporation date of ELOMATIC-PHARMALAB CONSULTING AND ENGINEERING PRIVATE LIMITED is 27 October, 2004

What is the authorized share capital of ELOMATIC-PHARMALAB CONSULTING AND ENGINEERING PRIVATE LIMITED?

plus icon

The authorized share capital of ELOMATIC-PHARMALAB CONSULTING AND ENGINEERING PRIVATE LIMITED is INR ₹ 7.5 Cr.

What is the paid-up capital of ELOMATIC-PHARMALAB CONSULTING AND ENGINEERING PRIVATE LIMITED?

plus icon

The paid-up capital of ELOMATIC-PHARMALAB CONSULTING AND ENGINEERING PRIVATE LIMITED is INR ₹ 5.2 Cr.

What is the registered address of ELOMATIC-PHARMALAB CONSULTING AND ENGINEERING PRIVATE LIMITED?

plus icon

The registered address of ELOMATIC-PHARMALAB CONSULTING AND ENGINEERING PRIVATE LIMITED is Centrum, Unit no. 301 to 304, Opp. TMC Office Next to Satkar Grande Hotel, Waghle Indl Estate Thane West Thane Maharashtra - 400604

What is the CIN number of ELOMATIC-PHARMALAB CONSULTING AND ENGINEERING PRIVATE LIMITED?

plus icon

The CIN number of ELOMATIC-PHARMALAB CONSULTING AND ENGINEERING PRIVATE LIMITED is U73100MH2004PTC149278.

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More